Keywords: zlb, behring, donates, million, hemophilia, drugs, created

ZLB Behring donates $9.8 million of hemophilia drugs

Article | 01 November 2004

Print This

ZLB Behring, created via the integration Australian firm CSL's ZLB Bioplasma unit and Aventis Behring, acquired from the former Franco-German ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in